Latest financial market updates and expert analysis
Analysis Cogent Biosciences recently showcased compelling long-term efficacy data for its lead drug candidate, bezuclastinib, at the 2026 American Academy of Allergy Asthma & Immunology (AAAAI) annual meeting. The findings, drawn...
March 2026 marked a potential inflection point for Plug Power. The company reported annual figures that surpassed expectations, delivered a...
The company’s strategic focus on Apple’s hardware ecosystem continues to intensify. Socket Mobile, a specialist in data capture solutions, has...
Sangamo Therapeutics has initiated a rolling Biologics License Application (BLA) submission with the U.S. Food and Drug Administration for its...
The cybersecurity giant Palo Alto Networks is navigating a significant strategic transformation. Its shift toward an AI-native security platform is...
Amazon continues to demonstrate its ambition far beyond e-commerce and cloud computing. The tech behemoth is aggressively pursuing growth in...
Zscaler’s management team is addressing the investment community this Tuesday, presenting at two major industry conferences in New York. Following...
The coming weeks represent a critical period for Shanghai Pharmaceuticals Holding Co., Ltd. (ADR). As China’s pharmaceutical sector undergoes a...
The Walt Disney Company is currently steering through a complex array of market pressures. Investors are closely monitoring how the...
For investors in MedGen Inc, the broader market environment for healthcare’s smallest companies is currently a primary consideration. In the...
The financial year 2025 concluded with robust gains in both revenue and profit for Adyen NV. While a more cautious...
